RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      Balsalazide induced myocarditis in patient with ulcerative colitis: a case report

      한글로보기

      https://www.riss.kr/link?id=A108208790

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      Myocarditis induced by 5-aminosalicylic acid (ASA) is a rare and idiosyncratic adverse event requiring discontinuation of the drug. There have been very few cases of balsalazide induced myocarditis. Balsalazide is known to cause less complications compared to mesalamine due to its lower serum concentration. However, in the case of idiosyncratic adverse effects, clinicians should be aware that all 5-ASA drug have the potential to cause myocarditis in patients with ulcerative colitis (UC). We report a case of balsalazide induced myocarditis in a 26-year-old female patient with UC. She was treated UC with balsalazide and added topical mesalamine one month ago. Her myocarditis was improved by discontinuation of basalazide and topical mesalamine. We considered a recently added topical mesalamine as a cause of myocarditis. Although basalazide is 5-ASA, it was carefully re-introduction because it was previously well tolerable. Finally, balsalazide induced myocarditis was confirmed by recurrence of myocarditis
      번역하기

      Myocarditis induced by 5-aminosalicylic acid (ASA) is a rare and idiosyncratic adverse event requiring discontinuation of the drug. There have been very few cases of balsalazide induced myocarditis. Balsalazide is known to cause less complications com...

      Myocarditis induced by 5-aminosalicylic acid (ASA) is a rare and idiosyncratic adverse event requiring discontinuation of the drug. There have been very few cases of balsalazide induced myocarditis. Balsalazide is known to cause less complications compared to mesalamine due to its lower serum concentration. However, in the case of idiosyncratic adverse effects, clinicians should be aware that all 5-ASA drug have the potential to cause myocarditis in patients with ulcerative colitis (UC). We report a case of balsalazide induced myocarditis in a 26-year-old female patient with UC. She was treated UC with balsalazide and added topical mesalamine one month ago. Her myocarditis was improved by discontinuation of basalazide and topical mesalamine. We considered a recently added topical mesalamine as a cause of myocarditis. Although basalazide is 5-ASA, it was carefully re-introduction because it was previously well tolerable. Finally, balsalazide induced myocarditis was confirmed by recurrence of myocarditis

      더보기

      참고문헌 (Reference)

      1 Harbord M, "The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease" 10 : 239-254, 2016

      2 Sehgal P, "Systematic review : safety of mesalazine in ulcerative colitis" 47 : 1597-1609, 2018

      3 Green JR, "Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis : a 3-year prospective observational study" 19 : 435-442, 2004

      4 Haq MI, "Mesalazine-induced cardiotoxicity" 4 : 24-, 2019

      5 Raine T, "ECCO guidelines on therapeutics in ulcerative colitis : medical treatment" 16 : 2-17, 2022

      6 Bunu DM, "Cardiovascular manifestations of inflammatory bowel disease : pathogenesis, diagnosis, and preventive strategies" 2019 : 3012509-, 2019

      7 Robertson E, "Balsalazide-induced myocarditis" 130 : e121-e122, 2008

      8 Patil SA, "Balsalazide disodium for the treatment of ulcerative colitis" 2 : 177-184, 2008

      1 Harbord M, "The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease" 10 : 239-254, 2016

      2 Sehgal P, "Systematic review : safety of mesalazine in ulcerative colitis" 47 : 1597-1609, 2018

      3 Green JR, "Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis : a 3-year prospective observational study" 19 : 435-442, 2004

      4 Haq MI, "Mesalazine-induced cardiotoxicity" 4 : 24-, 2019

      5 Raine T, "ECCO guidelines on therapeutics in ulcerative colitis : medical treatment" 16 : 2-17, 2022

      6 Bunu DM, "Cardiovascular manifestations of inflammatory bowel disease : pathogenesis, diagnosis, and preventive strategies" 2019 : 3012509-, 2019

      7 Robertson E, "Balsalazide-induced myocarditis" 130 : e121-e122, 2008

      8 Patil SA, "Balsalazide disodium for the treatment of ulcerative colitis" 2 : 177-184, 2008

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2025 평가예정 재인증평가 신청대상 (재인증)
      2022-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2020-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼